Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial

(2022) E Wesley Ely et al.   Lancet Respiratory Medicine

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

(2022) Cameron R Wolfe et al.   Lancet Respiratory Medicine

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

(2022) Obbina Abani et al.   LANCET

Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients

(2021) Noa Shafran et al.   Scientific Reports

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial

(2021) Andre C Kalil et al.   Lancet Respiratory Medicine

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

(2021) Vincent C Marconi et al.   Lancet Respiratory Medicine

Is Ventilator-Associated Pneumonia More Frequent in Patients With Coronavirus Disease 2019?

(2021) Andre C. Kalil et al.   CRITICAL CARE MEDICINE

COVID-19: combining antiviral and anti-inflammatory treatments

(2020) Justin Stebbing et al.   LANCET INFECTIOUS DISEASES

Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

(2020) Justin Stebbing et al.   EMBO Molecular Medicine

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

(2020) Kevin L Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

(2020) Andre C. Kalil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reporting infections in clinical trials of patients with haematological alignancies – A systematic review

(2019) Noam Tau et al.   CLINICAL MICROBIOLOGY AND INFECTION